Duchenne Muscular Dystrophy (DMD) is a serious genetic disease affecting young boys, causing muscle weakness and heart problems. This study tests a medicine called ifetroban to help with heart issues in DMD patients. The study involves taking a pill daily for 12 months. There are three groups: low-dose ifetroban, high-dose ifetroban, or a placebo (a pill with no medicine). The study is double-blind, meaning neither the participants nor the doctors know who is getting the medicine or placebo.
- Duration: 12 months with daily medication.
- Eligibility: Males 7 and older with DMD; heart function criteria must be met.
- Risks: Possible side effects are monitored; no major surgeries during the study.
Participants must be stable on certain heart medications before joining. Blood and urine tests will be done to check the medicine's effects. This study aims to find a new way to help young men with DMD live longer and healthier lives by addressing heart problems.